JP2016512232A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512232A5
JP2016512232A5 JP2015562913A JP2015562913A JP2016512232A5 JP 2016512232 A5 JP2016512232 A5 JP 2016512232A5 JP 2015562913 A JP2015562913 A JP 2015562913A JP 2015562913 A JP2015562913 A JP 2015562913A JP 2016512232 A5 JP2016512232 A5 JP 2016512232A5
Authority
JP
Japan
Prior art keywords
hydroxypropyl
carbamate
chlorophenyl
group
dichlorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015562913A
Other languages
English (en)
Japanese (ja)
Other versions
JP6200526B2 (ja
JP2016512232A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2014/002005 external-priority patent/WO2014142518A1/en
Publication of JP2016512232A publication Critical patent/JP2016512232A/ja
Publication of JP2016512232A5 publication Critical patent/JP2016512232A5/ja
Application granted granted Critical
Publication of JP6200526B2 publication Critical patent/JP6200526B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015562913A 2013-03-12 2014-03-11 運動障害の予防又は治療用フェニルカルバメート化合物 Active JP6200526B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361776926P 2013-03-12 2013-03-12
US61/776,926 2013-03-12
PCT/KR2014/002005 WO2014142518A1 (en) 2013-03-12 2014-03-11 Phenyl carbamate compounds for use in preventing or treating a movement disorder

Publications (3)

Publication Number Publication Date
JP2016512232A JP2016512232A (ja) 2016-04-25
JP2016512232A5 true JP2016512232A5 (enExample) 2017-08-31
JP6200526B2 JP6200526B2 (ja) 2017-09-20

Family

ID=51530016

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2015562906A Active JP6062077B2 (ja) 2013-03-12 2014-03-07 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes}
JP2015562915A Active JP6062078B2 (ja) 2013-03-12 2014-03-11 てんかん及びてんかん−関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreentingortreatingpediatricepilesyandepilesy−relatedsyndromes}
JP2015562914A Active JP6215971B2 (ja) 2013-03-12 2014-03-11 てんかん又はてんかん−関連症侯群の予防又は治療用フェニルアルキルカルバメート化合物{phenylalkylcarbamatecompoundsforuseinpreventingortreatingepilepsyorepilepsy−relatedsyndrome}
JP2015562913A Active JP6200526B2 (ja) 2013-03-12 2014-03-11 運動障害の予防又は治療用フェニルカルバメート化合物
JP2017133937A Pending JP2017206546A (ja) 2013-03-12 2017-07-07 てんかん又はてんかん−関連症侯群の予防又は治療用フェニルアルキルカルバメート化合物{phenyl alkyl carbamate compoundsfor use in preventing or treating epilepsy or epilepsy−related syndrome}

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2015562906A Active JP6062077B2 (ja) 2013-03-12 2014-03-07 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes}
JP2015562915A Active JP6062078B2 (ja) 2013-03-12 2014-03-11 てんかん及びてんかん−関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreentingortreatingpediatricepilesyandepilesy−relatedsyndromes}
JP2015562914A Active JP6215971B2 (ja) 2013-03-12 2014-03-11 てんかん又はてんかん−関連症侯群の予防又は治療用フェニルアルキルカルバメート化合物{phenylalkylcarbamatecompoundsforuseinpreventingortreatingepilepsyorepilepsy−relatedsyndrome}

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017133937A Pending JP2017206546A (ja) 2013-03-12 2017-07-07 てんかん又はてんかん−関連症侯群の予防又は治療用フェニルアルキルカルバメート化合物{phenyl alkyl carbamate compoundsfor use in preventing or treating epilepsy or epilepsy−related syndrome}

Country Status (7)

Country Link
US (5) US9872847B2 (enExample)
EP (4) EP2968210B1 (enExample)
JP (5) JP6062077B2 (enExample)
KR (5) KR101717872B1 (enExample)
CN (6) CN105228604A (enExample)
ES (3) ES2998534T3 (enExample)
WO (4) WO2014142477A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2998534T3 (en) * 2013-03-12 2025-02-20 Bio Pharm Solutions Co Ltd Phenyl carbamate compounds for use in preventing or treating pediatric epilesy
CN105189450B (zh) 2013-03-12 2019-09-13 比皮艾思药物研发有限公司 氨基甲酸苯酯化合物及包含该化合物的用于预防或治疗精神障碍的组合物
WO2017150903A1 (en) 2016-02-29 2017-09-08 Bio-Pharm Solutions Co., Ltd. Sulfamate derivative compounds, processes for preparing them and their uses
KR102635941B1 (ko) * 2016-12-14 2024-02-13 에스케이바이오팜 주식회사 진전 또는 진전 증후군의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
CN109920550A (zh) * 2018-12-25 2019-06-21 天津大学 一种基于dMRI研究青少年肌阵挛性癫痫的方法
EP4204395A4 (en) * 2020-08-31 2024-08-07 Bio-Pharm Solutions Co., Ltd. Phenyl alkyl carbamate compounds for use in preventing or treating neurodegenerative disease
EP4211125A4 (en) 2020-09-10 2024-10-02 Bio-Pharm Solutions Co., Ltd. SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING A PSYCHIATRIC DISORDER
US12054449B2 (en) 2021-08-05 2024-08-06 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate crystalline form and method for manufacturing the same
CN119552104B (zh) * 2024-12-03 2025-07-15 西安瑞谱源生物技术有限公司 一种氘代维生素a的制备方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3313697A (en) 1962-06-26 1967-04-11 Armour Pharma Carbamate compositions for and methods of treating the central nervous system
US3313696A (en) 1962-06-26 1967-04-11 Armour Pharmacentical Company Carbamate sedative compositions and method of use
US3313699A (en) 1962-06-26 1967-04-11 Armour Pharma Compositions for and method of treating the central nervous system
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US3313700A (en) * 1962-07-18 1967-04-11 Armour Pharmacentical Company Method of treating the central nervous system with substituted phenethyl carbamates and compositions therefor
FR5671M (enExample) * 1965-04-23 1968-01-02
JPS61271992A (ja) 1985-05-28 1986-12-02 Central Glass Co Ltd 光学活性ジオ−ルの製造方法
US5258397A (en) 1988-11-30 1993-11-02 Novapharme 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions
FR2686084B1 (fr) * 1992-01-10 1995-12-22 Bioprojet Soc Civ Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
KR100197901B1 (ko) * 1994-02-21 1999-06-15 남창우 페닐-1,2-에탄디올 광학이성체의 단일 카바메이트
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
US5698588A (en) 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US20010034365A1 (en) * 1996-01-16 2001-10-25 Choi Yong Moon Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
WO2002051395A1 (en) 1998-05-28 2002-07-04 Codon Pharmaceuticals, Inc. Treatment of neurodegenerative diseases
AR020115A1 (es) * 1998-08-06 2002-04-10 Daiichi Seiyaku Co Agente terapeutico o preventivo para epilepsias rebeldes y uso del compuesto para la produccion de los mismos
CN1503665A (zh) 2001-02-27 2004-06-09 ����-������ҩƷ��˾ 用于预防或治疗焦虑症的氨基甲酸酯化合物
JP2004527492A (ja) * 2001-02-27 2004-09-09 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 運動障害の予防もしくは治療における使用のためのカルバメート化合物
RU2283106C2 (ru) 2001-02-27 2006-09-10 Орто-Макнейл Фармасьютикал, Инк. Производные карбаматов для использования для лечения боли
PT1383489E (pt) 2001-02-27 2007-06-21 Ortho Mcneil Pharm Inc Compostos carbamato para utilização na prevenção ou tratamento de distúrbios neurodegenerativos
PT1401424E (pt) 2001-02-27 2007-02-28 Ortho Mcneil Pharm Inc Compostos carbamato para utilização na prevenção ou tratamento de distúrbios psicóticos
US7199135B2 (en) * 2001-07-05 2007-04-03 H. Lundbeck A/S Substituted alkyl amido piperidines
JP4635130B2 (ja) * 2002-06-11 2011-02-16 株式会社医薬分子設計研究所 神経変性疾患治療剤
DK1809273T3 (da) 2004-09-16 2010-08-02 Janssen Pharmaceutica Nv Anvendelse af 2-phenyl-1,2-ethandiol-(di)carbamater til behandling af epileptogenese
EP1717235A3 (en) * 2005-04-29 2007-02-28 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
US7737141B2 (en) 2006-07-28 2010-06-15 Eisai R&D Management Co., Ltd. Prodrug of cinnamide compound
AU2007313017A1 (en) 2006-10-13 2008-04-24 Janssen Pharmaceutica, N.V. Phenylalkylamino carbamate compositions
MX2009003929A (es) * 2006-10-13 2009-06-26 Janssen Pharmaceutica Nv Composiciones de fenilalquil carbamato.
EP2079465A2 (en) 2006-10-27 2009-07-22 Janssen Pharmaceutica N.V. Methods for treatment of cochlear and vestibular disorders
JP2010508355A (ja) 2006-10-30 2010-03-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 鬱病を処置する方法
US7863499B2 (en) 2007-02-08 2011-01-04 Albert Einstein College Of Medicine Of Yeshiva University Model of infantile spasm syndrome
JP2010524858A (ja) 2007-04-10 2010-07-22 エスジーエックス ファーマシューティカルズ、インコーポレイテッド 縮合環複素環キナーゼ調節因子
CN102159077A (zh) 2008-08-21 2011-08-17 吉瑞工厂 用于治疗神经性疼痛的方法
AU2009300607C1 (en) 2008-10-02 2014-08-07 Taisho Pharmaceutical Co., Ltd. 7-piperidinoalkyl-3,4-dihydroquinolone derivative
CN102448937A (zh) 2009-05-29 2012-05-09 拉夸里亚创药株式会社 作为钙或钠通道阻滞剂的芳基取代羧酰胺衍生物
JP2013501026A (ja) * 2009-08-05 2013-01-10 クオンベルゲンセ プハルマセウトイカルス リミテッド てんかん及び関連疾患の治療のための共治療法
KR101532823B1 (ko) * 2010-07-02 2015-07-03 (주)바이오팜솔루션즈 페닐 카바메이트 화합물 및 이를 포함하는 근육 이완제
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
CA2815460C (en) * 2011-01-13 2017-04-18 Bio-Pharm Solutions Co., Ltd. Process for preparation of phenyl carbamate derivatives
EP2797878B1 (en) 2011-12-27 2017-08-16 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating stroke
CN105189450B (zh) 2013-03-12 2019-09-13 比皮艾思药物研发有限公司 氨基甲酸苯酯化合物及包含该化合物的用于预防或治疗精神障碍的组合物
ES2998534T3 (en) * 2013-03-12 2025-02-20 Bio Pharm Solutions Co Ltd Phenyl carbamate compounds for use in preventing or treating pediatric epilesy

Similar Documents

Publication Publication Date Title
JP2016512232A5 (enExample)
ES2624989T3 (es) Compuestos fenilcarbamato para uso en la prevención o en el tratamiento de la epilepsia
JP5838226B2 (ja) フェニルカルバメート誘導体の製造方法
JP6200526B2 (ja) 運動障害の予防又は治療用フェニルカルバメート化合物
CN105189450B (zh) 氨基甲酸苯酯化合物及包含该化合物的用于预防或治疗精神障碍的组合物
JP2012532883A5 (enExample)
CA3035121A1 (en) Fused tricyclic .gamma.-amino acid derivative, preparation method therefor, and medical use thereof
CN104628603B (zh) 苯基氨基甲酸酯化合物及含有苯基氨基甲酸酯化合物的肌肉松弛剂
JP2013545728A5 (enExample)
HK1182376A (en) Phenylcarbamate compound and muscle relaxant containing the same